RED OAK Medicines
Natick, US · Founded 2017 · Delaware corporation
Founders & leadership
HL
Hongtao LiPresident and Director
MF
Michael FrankenChief Executive Officer
DS
David Scadden, MDNamed on SEC filing
YW
Yong WangNamed on SEC filing
Board
WH
Walter HuangSecretary and Director
Reported raises · per SEC filings
Form D private placements$2.1M disclosed across 1 round · 2017
▶$2.1MraisedApr 2018 · 4 investors · PharmaceuticalsRule 506(b)
▶$2.1MraisedApr 2018 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Walter HuangExecutive Officer
- David Scadden, MDDirector
- Hongtao LiExecutive Officer, Director
- Michael FrankenExecutive Officer
- Yong WangDirector
- Offering amount
- $5.1M
- Amount sold
- $2.1M
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has RED OAK Medicines raised?
- RED OAK Medicines has disclosed $2.1M raised across 1 round.
- Where is RED OAK Medicines headquartered?
- RED OAK Medicines is headquartered in Natick, US.